DC publications
Director’s Challenge Bibliography
-
Adamson E, de Belle I, Mittal S, Wang Y, Hayakawa
J, Korkmaz K, O'Hagan D, McClelland M, Mercola D. (2003). Egr1 signaling
in prostate cancer.Cancer Biol Ther. 2:617-622.
-
Adamson ED, Mercola D. (2002).
Egr1 transcription factor: multiple roles in prostate tumor cell growth
and survival. Tumour Biol. 23:93-102. Review.
-
Agrawal D, Chen T, Irby R, Quackenbush J,
Chambers AF, Szabo M, Cantor A, Coppola D, Yeatman TJ. (2002). Osteopontin
identified as lead marker of colon cancer progression, using pooled sample
expression profiling. J Natl Cancer Inst 94:513-521.
-
Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos
IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L,
Marti GE, Moore T, Hudson J, Jr, Lu L, Lewis DB, Tibshirani R, Sherlock
G, Chan WC, Greiner TC, Weisenburger, DD, Armitage JO, Warnke R, Staudt
LM, et al. (2000). Distinct types of diffuse large B-cell lymphoma identified
by gene expression profiling. Nature 403:503-511.
-
Alter O, Brown PO, Botstein D. (2000). Singular
value decomposition for genome-wide expression data processing and modeling.
Proc Natl Acad Sci USA 97:10101-10106.
-
Alter O, Brown PO, Botstein D. (2003). Generalized
singular value decomposition for comparative analysis of genome-scale expression
data sets of two different organisms. Proc Natl Acad Sci USA 100: 3351-3356.
-
Arango D, Corner GA, Wadler S, Catalano PJ,
Augenlicht LH. (2001). c-myc/p53 interaction determines sensitivity of
human colon carcinoma cells to 5-fluorouracil in vitro and in vivo. Cancer
Res. 61:4910-4915.
-
Arango D, Mariadason JM, Wilson AJ, Yang W,
Corner GA, Nicholas C, Aranes MJ, Augenlicht LH. (2003) c-Myc overexpression
sensitises colon cancer cells to camptothecin-induced apoptosis. Br J Cancer.
89:1757-1765.
-
Augenlicht LH, Mariadason JM, Wilson A, Arango
D, Yang W, Heerdt BG, Velcich, A. (2002). Short chain Fatty acids and colon
cancer. J Nutr 132: 3804S-3808S.
-
Augenlicht LH, Velcich A, Klampfer L, Huang
J, Corner G, Aranes M, Laboisse C, Rigas B, Lipkin M, Yang K, Shi Q, Lesser
M, Heerdt B, Arango D, Yang W, Wilson A, Mariadason JM. (2003) Application
of gene expression profiling to colon cell maturation, transformation and
chemoprevention. J Nutr. 133:2410S-2416S.
-
Baggerly KA, Deng L, Morris JS, Aldaz CM.
(2003). Differential expression in SAGE: accounting for normal between-library
variation. Bioinformatics. 19:1477-1483.
-
Beer DG, Kardia SL, Huang CC, Giordano TJ,
Levin AM, Misek DE, Lin L, Chen G, Gharib TG, Thomas DG, Lizyness ML, Kuick
R, Hayasaka S, Taylor JM, Iannettoni MD, Orringer MB, Hanash S. (2002).
Gene-expression profiles predict survival of patients with lung adenocarcinoma.
Nat Med. 8:816-824.
-
Bhattacharjee A, Richards WG, Staunton J,
Li C, Monti S, Vasa P, Ladd C, Beheshti J, Bueno R, Gillette M, Loda M,
Weber G, Mark EJ, Lander ES, Wong W, Johnson BE, Golub TR, Sugarbaker DJ,
Meyerson M. (2001). Classification of human lung carcinomas by mRNA expression
profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci
USA. 98:13790-13795.
-
Bloom G, Yang IV, Boulware D, Kwong KY, Coppola
D, Eschrich S, Quackenbush J, Yeatman TJ. (2004). Multi-platform, multi-site,
microarray-based human tumor classification. Am J Pathol. 164:9-16.
-
Bohen SP, Troyanskaya OG, Alter O, Warnke
R, Botstein D, Brown PO, Levy R. (2003). Variation in gene expression patterns
in follicular lymphoma and the response to rituximab. Proc Natl Acad Sci
USA. 100:1926-1930.
-
Boon K, Edwards JB, Siu IM, Olschner D, Eberhart
CG, Marra MA, Strausberg RL, Riggins GJ. (2003). Comparison of medulloblastoma
and normal neural transcriptomes identifies a restricted set of activated
genes. Oncogene. 22:7687-7694.
-
Boon K, Osório EC, Greenhut SF, Schaefer
CF, Shoemaker J, Polyak K, Morin PJ, Buetow KH, Strausberg RL, de Souza
SJ, Riggins. GJ. (2002). An anatomy of normal and malignant gene expression.
Proc Natl Acad Sci USA. 99:11287-11292.
-
Brooks JD. (2002) Microarray analysis in prostate
cancer research. Curr Opin Urol. 12:395-399.
-
Brunschwig EB, Wilson K, Mack D, Dawson D,
Lawrence E, Willson JK, Lu S, Nosrati A, Rerko RM, Swinler S, Beard L,
Lutterbaugh JD, Willis J, Platzer P, Markowitz S. (2003). PMEPA1, a transforming
growth factor-beta-induced marker of terminal colonocyte differentiation
whose expression is maintained in primary and metastatic colon cancer.
Cancer Res. 63:1568-1575.
-
Chang HY, Chi J-T, Dudoit S, Bondre C, van
de Rijn M, Botstein D, Brown PO. (2002). Diversity, topographic differentiation,
and positional memory in human fibroblasts. Proc Natl Acad Sci USA. 99:
12877-12882.
-
Chan WC, Hans CP. (2003). Genetic and molecular
genetic studies in the diagnosis of T and NK cell neoplasia. Hum Pathol.
34:314-321.
-
Chan WC, Huang JZ. (2001). Gene expression
analysis in aggressive NHL. Ann Hematol. 80 Suppl 3:B38-41.
-
Chang HY, Sneddon JB, Alizadeh AA, Sood R,
West RB, Montgomery K, Chi JT, Rijn Mv M, Botstein D, Brown PO. (2004).
Gene Expression Signature of Fibroblast Serum Response Predicts Human Cancer
Progression: Similarities between Tumors and Wounds. PLoS Biol 2:E7.
Epub.
-
Chen X, Cheung ST, So S, Fan ST, Barry C,
Higgins J, Lai KM, Ji J, Dudoit S, Ng IO, Van De Rijn M, Botstein D, Brown
PO. (2002). Gene expression patterns in human liver cancers. Mol Biol Cell.
13:1929-1939.
-
Chen G, Gharib TG, Huang CC, Taylor JM, Misek
DE, Kardia SL, Giordano TJ, Iannettoni MD, Orringer MB, Hanash SM, Beer
DG. (2002). Discordant protein and mRNA expression in lung adenocarcinomas.
Mol Cell Proteomics 1:304-313.
-
Chen G, Gharib TG, Huang CC, Thomas DG, Shedden
KA, Taylor JM, Kardia SL, Misek DE, Giordano TJ, Iannettoni MD, Orringer
MB, Hanash SM, Beer DG. (2002). Proteomic analysis of lung adenocarcinoma:
identification of a highly expressed set of proteins in tumors. Clin Cancer
Res. 8:2298-2305.
-
Chen G, Gharib TG, Thomas DG, Huang CC, Misek
DE, Kuick RD, Giordano TJ, Iannettoni MD, Orringer MB, Hanash SM, Beer
DG. (2003). Proteomic analysis of eIF-5A in lung adenocarcinomas. Proteomics.
3:496-504.
-
Chen G, Gharib TG, Wang H, Huang CC, Kuick
R, Thomas DG, Shedden KA, Misek DE, Taylor JM, Giordano TJ, Kardia SL,
Iannettoni MD, Yee J, Hogg PJ, Orringer MB, Hanash SM, Beer DG. (2003 ).
Protein profiles associated with survival in lung adenocarcinoma. Proc
Natl Acad Sci USA. 100:13537-13542.
-
Chen X, Leung SY, Yuen ST, Chu KM, Ji J, Li
R, Chan AS, Law S, Troyanskaya OG, Wong J, So S, Botstein D, Brown PO.
(2003). Variation in gene expression patterns in human gastric cancers.
Mol Biol Cell. 14:3208-3215.
-
Chen G, Wang H, Gharib TG, Huang CC, Thomas
DG, Shedden KA, Kuick R, Taylor JM, Kardia SL, Misek DE, Giordano TJ, Iannettoni
MD, Orringer MB, Hanash SM, Beer DG. (2003). Overexpression of oncoprotein
18 correlates with poor differentiation in lung adenocarcinomas. Mol Cell
Proteomics. 2:107-116.
-
Chen G, Wang H, Miller CT, Thomas DG, Gharib
TG, Misek DE, Giordano TJ, Orringer MB, Hanash SM, Beer DG. (2004). Reduced
selenium-binding protein 1 expression is associated with poor outcome in
lung adenocarcinomas. J Pathol 202:321-329.
-
Chen T, Yang I, Irby R, Shain KH, Wang HG,
Quackenbush J, Coppola D, Cheng JQ, Yeatman TJ. (2003). Regulation of caspase
expression and apoptosis by adenomatous polyposis coli. Cancer Res. 63:4368-4374.
-
Chi JT, Chang HY, Haraldsen G, Jahnsen FL,
Troyanskaya OG, Chang DS, Wang Z, Rockson SG, Van De Rijn M, Botstein D,
Brown PO. (2003). Endothelial cell diversity revealed by global expression
profiling. Proc Natl Acad Sci USA. 100:10623-10628.
-
Chi JT, Chang HY, Wang NN, Chang DS, Dunphy
N, Brown PO. (2003). Genomewide view of gene silencing by small interfering
RNAs. Proc Natl Acad Sci USA.100:6343-6346.
-
Choe G, Horvath S, Cloughesy TF, Crosby K,
Seligson D, Palotie A, Inge L, Smith BL, Sawyers CL, Mischel PS. (2003).
Analysis of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma
patients in vivo. Cancer Res. 63:2742-2746.
-
Coppola D, Szabo M, Boulware D, Muraca P,
Alsarraj M, Chambers AF, Yeatman TJ. (2004). Correlation of osteopontin
protein expression and pathological stage across a wide variety of tumor
histologies. Clin Cancer Res. 10:184-190.
-
Crawford EL, Peters GJ, Noordhuis P, Rots
MG, Vondracek M, Grafstrom RC, Lieuallen K, Lennon G, Zahorchak RJ, Georgeson
MJ, Wali A, Lechner JF, Fan PS, Kahaleh MB, Khuder SA, Warner KA, Weaver
DA, Willey JC. (2001). Reproducible gene expression measurement among
multiple laboratories obtained in a blinded study using standardized RT
(StaRT)-PCR. Mol Diagn. 6:217-225.
-
Crawford EL, Warner KA, Khuder SA, Zahorchak
RJ, Willey JC. (2002). Multiplex standardized RT-PCR for expression
analysis of many genes in small samples. Biochem Biophys Res Commun. 293:509-516.
-
Creighton C, Hanash S, Beer D. (2003). Gene
expression patterns define pathways correlated with loss of differentiation
in lung adenocarcinomas. FEBS Lett. 540:167-170.
-
Cuezva JM, Chen G, Alonso AM, Isidoro A, Misek
DE, Hanash SM, Beer DG. (2004). The bioenergetic signature of lung adenocarcinomas
is a molecular marker of cancer diagnosis and prognosis. Carcinogenesis
[Epub ahead of print]
-
Dave BJ, Nelson M, Pickering DL, Chan WC,
Greiner TC, Weisenburger DD, Armitage JO, Sanger WG. (2002 ). Cytogenetic
characterization of diffuse large cell lymphoma using multi-color fluorescence
in situ hybridization. Cancer Genet Cytogenet. 132:125-132.
-
Davis RE, Staudt LM. (2002). Molecular diagnosis
of lymphoid malignancies by gene expression profiling. Curr Opin Hematol.
9:333-338.
-
DePrimo SE, Diehn M, Nelson JB, Reiter RE,
Matese J, Fero M, Tibshirani R,Brown PO, Brooks JD. (2002). Transcriptional
programs activated by exposure of human prostate cancer cells to androgen.
Genome Biol. 3:RESEARCH0032
-
Diehn M., Alizadeh AA, Brown PO. (2000). Examining
the living genome in health and disease with DNA microarrays. JAMA. 283,
2298-2299.
-
Diehn M, Alizadeh AA, Rando OJ, Liu
CL, Stankunas K, Botstein D, Crabtree GR, Brown PO. (2002). Genomic expression
programs and the integration of the CD28 costimulatory signal in T cell
activation. Proc Natl Acad Sci USA. 99: 11796-11801.
-
Diehn M, Binkley G, Jin H, Matese JC, Hernandez-Boussard
T, Rees CA, Cherry JM, Sherlock G, Botstein D, Brown PO. (2003). SOURCE:
A Unified Genomic Resource of Functional Annotations, Ontologies and Gene
Expression Data. Nucl. Acids Res. 31:219-223.
-
Fang NY, Greiner TC, Weisenburger DD, Chan
WC, Vose JM, Smith LM, Armitage JO, Mayer RA, Pike BL, Collins FS, Hacia
JG. (2003). Oligonucleotide microarrays demonstrate the highest frequency
of ATM mutations in the mantle cell subtype of lymphoma. Proc Natl Acad
Sci USA. 100:5372-5377.
-
Febbo PG, Sellers WR. (2003). Use of expression
analysis to predict outcome after radical prostatectomy. J Urol. 170:S11-9;
discussion S19-20.
-
Finlin BS, Gau CL, Murphy GA, Shao H, Kimel
T, Seitz RS, Chiu YF, Botstein D, Brown PO, Der CJ, Tamanoi F, Andres DA,
Perou CM. (2001). RERG is a novel ras-related, estrogen-regulated and growth-inhibitory
gene in breast cancer. J Biol Chem. 276:42259-42267.
-
Friedman CP, Ozbolt JG, Masys DR. (2001).
Toward a new culture for biomedical informatics: report of the 2001 ACMI
symposium. J Am Med Inform Assoc. 8:519-526.
-
Garber ME, Troyanskaya OG, Schluens K, Petersen
S, Thaesler Z, Pacyna-Gengelbach M, van de Rijn M, Rosen GD, Perou CM,
Whyte RI, Altman RB, Brown PO, Botstein D, Petersen I. (2001). Diversity
of gene expression in adenocarcinoma of the lung. Proc Natl Acad
Sci USA. 98:13784-13789.
-
Gascoyne RD, Lamant L, Martin-Subero JI, Lestou
VS, Harris NL, Muller-Hermelink HK, Seymour JF, Horsman DE, Auvigne I,
Espinos E, Siebert R, Delsol G. (2003). ALK-positive diffuse large B-cell
lymphoma is associated with Clathrin-ALK rearrangements: report of six
cases. Blood. 102:2568-2573.
-
Gerald WL. (2003). Genome-wide gene expression
analysis of prostate carcinoma. Semin Oncol. 30:635-648. Review.
-
Gharib TG, Chen G, Wang H, Huang CC, Prescott
MS, Shedden K, Misek DE, Thomas DG, Giordano TJ, Taylor JM, Kardia S, Yee
J, Orringer MB, Hanash S, Beer DG. (2002). Proteomic analysis of cytokeratin
isoforms uncovers association with survival in lung adenocarcinoma. Neoplasia
4:440-448.
-
Giordano TJ, Shedden KA, Schwartz DR, Kuick
R, Taylor JM, Lee N, Misek DE, Greenson JK, Kardia SL, Beer DG, Rennert
G, Cho KR, Gruber SB, Fearon ER, Hanash S. (2001). Organ-specific molecular
classification of primary lung, colon, and ovarian adenocarcinomas
using gene expression profiles. Am J Pathol. 159:1231-1238.
-
Giordano TJ, Thomas DG, Kuick R, Lizyness
M, Misek DE, Smith AL, Sanders D, Aljundi RT, Gauger PG, Thompson NM, Taylor
JM, Hanash SM. (2003). Distinct transcriptional profiles of adenocortical
tumors uncovered by DNA microarray analysis. Am J Pathol. 162:521-531.
-
Glinsky GV, Krones-Herzig A, Glinskii AB,
Gebauer G. (2003). Microarray analysis of xenograft-derived cancer cell
lines representing multiple experimental models of human prostate cancer.
Mol Carcinog. 37:209-221.
-
Gollub J, Ball C, Binkley G, Demeter J, Hebert
G, Hernandez-Boussard T, Jin H, Kaloper M, Matese J, Schroeder M, Brown
PO, Botstein D, Sherlock G. (2003). The Stanford Microarray Database: Data
Access and Quality Assessment Tools. Nucl. Acids Res. 31:94-96.
-
Haab BB, Dunham MJ, Brown PO. (2001). Protein
microarrays for highly parallel detection and quantitation of specific
proteins and antibodies in complex solutions. Genome Biol 2, RESEARCH0004.
-
Hanash SM. (2001). Global profiling of gene
expression in cancer using genomics and proteomics. Curr Opin Mol Ther.
3:538-545. Review.
-
Hanash SM, Bobek MP, Rickman DS, Williams
T, Rouillard JM, Kuick R, Puravs E. (2002). Integrating cancer genomics
and proteomics in the post-genome era. Proteomics. 2:69-75.
-
Hanash S, Brichory F, Beer D. (2001). A proteomic
approach to the identification of lung cancer markers. Dis Markers. 17:295-300.
Review.
-
Hanash S, Creighton C. (2003). Making sense
of microarray data to classify cancer. Pharmacogenomics J. 3:308-311.
-
Hans CP, Weisenburger DD, Greiner TC, Gascoyne
RD, Delabie J, Ott G, Muller-Hermelink HK, Campo E, Braziel RM, Jaffe ES,
Pan Z, Farinha P, Smith LM, Falini B, Banham AH, Rosenwald A, Staudt LM,
Connors JM, Armitage JO, Chan WC. (2004). Confirmation of the molecular
classification of diffuse large B-cell lymphoma by immunohistochemistry
using a tissue microarray. Blood. 103:275-282.
-
Hastie T, Tibshirani R, Botstein D, Brown
P. (2001). Supervised harvesting of expression trees. Genome Biol 2, RESEARCH0003.
-
Hastie T, Tibshirani R, Eisen MB, Alizadeh
A, Levy R, Staudt L, Chan WC, Botstein D, Brown P. (2000). 'Gene shaving'
as a method for identifying distinct sets of genes with similar expression
patterns. Genome Biol 1, RESEARCH0003.
-
Hegde P, Qi R, Gaspard R, Abernathy K, Dharap
S, Earle-Hughes J, Gay C, Nwokekeh NU, Chen T, Saeed AI, Sharov V, Lee
NH, Yeatman TJ, Quackenbush J. (2001). Identification of tumor markers
in models of human colorectal cancer using a 19,200-element complementary
DNA microarray. Cancer Res. 61:7792-7797.
-
Higgins JP, Montgomery K, Wang L, Domanay
E, Warnke RA, Brooks JD, van de Rijn M. (2003). Expression of FKBP12 in
benign and malignant vascular endothelium: an immunohistochemical study
on conventional sections and tissue microarrays. Am J Surg Pathol. 27:58-64.
-
Higgins JT, Shinghal R, Gill H, Reese JH,
Terris M, Cohen RJ, Fero M, Pollack JR, van de Rijn M, Brooks JD. (2003).
Gene Expression Patterns in Renal Cell Carcinoma Assessed by Complementary
DNA Microarray. Am J Pathol. 162: 925-932.
-
Higgins JP, Wang L, Kambham N, Montgomery
K, Mason V, Vogelmann SU, Lemley KV, Brown PO, Brooks JD, van de Rijn M.
(2004). Gene expression in the normal adult human kidney assessed by complementary
DNA microarray. Mol Biol Cell. 15:649-656.
-
Hinoi T, Lucas PC, Kuick R, Hanash S, Cho
KR, Fearon ER. (2002). CDX2 regulates liver intestine-cadherin expression
in normal and malignant colon epithelium and intestinal metaplasia. Gastroenterology.
123:1565-1577.
-
Holterhus PM, Hiort O, Demeter J, Brown PO,
Brooks JD. (2003). Differential gene-expression patterns in genital fibroblasts
of normal males and 46,XY females with androgen insensitivity syndrome:
evidence for early programming involving the androgen receptor. Genome
Biol. 4:R37.
-
Holzbeierlein J, Lal P, LaTulippe E, Smith
A, Satagopan J, Zhang L, Ryan C, Smith S, Scher H, Scardino P, Reuter V,
Gerald WL. (2004). Gene expression analysis of human prostate carcinoma
during hormonal therapy identifies androgen-responsive genes and mechanisms
of therapy resistance. Am J Pathol. 164:217-227.
-
Horsman DE, Okamoto I, Ludkovski O, Le N,
Harder L, Gesk S, Siebert R, Chhanabhai M, Sehn L, Connors JM, Gascoyne
RD. (2003). Follicular lymphoma lacking the t(14;18)(q32;q21): identification
of two disease subtypes. British Journal of Haematology. 120:424-433.
-
Huang J, Qi R, Quackenbush J, Dauway E, Lazaridis
E, Yeatman T. (2001). Effects of ischemia on gene expression. J Surg Res.
99:222-227.
-
Huang JZ, Sanger WG, Greiner TC, Staudt LM,
Weisenburger DD, Pickering DL, Lynch JC, Armitage JO, Warnke RA, Alizadeh
AA, Lossos IS, Levy R, Chan WC. (2002). The t(14;18) defines a unique subset
of diffuse large B-cell lymphoma with a germinal center B-cell gene expression
profile. Blood 99:2285-2290.
-
Iacobuzio-Donahue CA, Maitra A, Olsen M, Lowe
AW, van Heek NT, Rosty C, Walter K, Sato N, Parker A, Ashfaq R, Jaffee
E, Ryu B, Jones J, Eshleman JR, Yeo CJ, Cameron JL, Kern SE, Hruban RH,
Brown PO, Goggins M. (2003). Exploration of global gene expression patterns
in pancreatic adenocarcinoma using cDNA microarrays. Am J Pathol. 162:1151-1162.
-
James AC, Veitch JG, Zareh AR, Triche T. (2004).
Sensitivity and specificity of five abundance estimators for high-density
oligonucleotide microarrays. Bioinformatics. [Epub ahead of print]
-
Jazaeri AA, Yee CJ, Sotiriou C, Brantley KR,
Boyd J, Liu ET. (2002). Gene expression profiles of BRCA1-linked, BRCA2-linked,
and sporadic ovarian cancers. J Natl Cancer Inst. 94:990-1000.
-
Kachman MT, Wang H, Schwartz DR, Cho KR, Lubman
DM. (2002). A 2-D liquid separations/mass mapping method for interlysate
comparison of ovarian cancers. Anal Chem. 74:1779-1791.
-
Kari L, Loboda A, Nebozhyn M, Rook AH, Vonderheid
EC, Nichols C, Virok D, Chang C, Horng WH, Johnston J, Wysocka M, Showe
MK, Showe LC. (2003). Classification and prediction of survival in patients
with the leukemic phase of cutaneous T cell lymphoma. J Exp Med. 197:1477-1488.
-
Khoury H, Lestou VS, Gascoyne RD, Bruyere
H, Li CH, Nantel SH, Dalal BI, Naiman SC, Horsman DE. (2003). Multicolor
karyotyping and clinicopathological analysis of three intravascular lymphoma
cases. Mod Pathol. 16:716-724.
-
Kim PJ, Plescia J, Clevers H, Fearon ER, Altieri
DC. (2003). Survivin and molecular pathogenesis of colorectal cancer. Lancet.
362:205-209.
-
Klampfer L, Huang J, Corner G, Mariadason
J, Arango D, Sasazuki T, Shirasawa S, Augenlicht L. (2003). Oncogenic k-ras
inhibits the expression of IFN-responsive genes through inhibition of STAT1
and STAT2 expression. J Biol Chem. 278:46278-46287.
-
Klampfer L, Huang J, Sasazuki T, Shirasawa
S, Augenlicht L. (2003). Inhibition of interferon gamma signaling by the
short chain fatty acid butyrate. Mol Cancer Res. 1:855-862.
-
Ladanyi M, Chan W C, Triche T J, Gerald W
L. (2001). Expression profiling of human tumors: the end of surgical pathology?
J Mol Diagn. 3:92-97.
-
Lal A, Glazer CA, Martinson HM, Friedman HS,
Archer GE, Sampson JH, Riggins GJ. (2002). Mutant Epidermal Growth Factor
Receptor Up-Regulates Molecular Effectors of Tumor Invasion. Cancer Res.
62:3335-3339.
-
Lamant L, Gascoyne RD, Duplantier MM, Armstrong
F, Raghab A, Chhanabhai M, Rajcan-Separovic E, Raghab J, Delsol G, Espinos
E. (2003). Non-muscle myosin heavy chain (MYH9): a new partner fused to
ALK in anaplastic large cell lymphoma. Genes Chromosomes Cancer. 37:427-432.
-
Lapointe J, Li C, Higgins JP, van de Rijn
M, Bair E, Montgomery K, Ferrari M, Egevad L, Rayford W, Bergerheim U,
Ekman P, DeMarzo AM, Tibshirani R, Botstein D, Brown PO, Brooks JD, Pollack
JR. (2004). Gene expression profiling identifies clinically relevant subtypes
of prostate cancer. Proc Natl Acad Sci USA. 101:811-816.
-
LaTulippe E, Satagopan J, Smith A, Scher H,
Scardino P, Reuter V, Gerald WL. (2002). Comprehensive gene expression
analysis of prostate cancer reveals distinct transcriptional programs associated
with metastatic disease. Cancer Res. 62:4499-4506.
-
Lau CC, Harris CP, Lu XY, Perlaky L, Gogineni
S, Chintagumpala M, Hicks J, Johnson ME, Davino NA, Huvos AG, Meyers PA,
Healy JH, Gorlick R, Rao PH. (2004). Frequent amplification and rearrangement
of chromosomal bands 6p12-p21 and 17p11.2 in osteosarcoma. Genes Chromosomes
Cancer. 39:11-21.
-
Lestou VS, Gascoyne RD, Sehn L, Ludkovski
O, Chhanabhai M, Klasa RJ, Husson H, Freedman AS, Connors JM, Horsman DE.
(2003). Multicolour fluorescence in situ hybridization analysis of t(14;18)-positive
follicular lymphoma and correlation with gene expression data and clinical
outcome. Br J Haematol. 122:745-759.
-
Lestou VS, Ludkovski O, Connors JM, Gascoyne
RD, Lam WL, Horsman DE. (2003). Characterization of the recurrent translocation
t(1;1)(p36.3;q21.1-2) in non-Hodgkin lymphoma by multicolor banding and
fluorescence in situ hybridization analysis. Genes Chromosomes Cancer.
36:375-381.
-
Leung JY, Kolligs FT, Wu R, Zhai Y, Kuick
R, Hanash S, Cho KR, Fearon ER. (2002). Activation of AXIN2 expression
by beta-catenin-T cell factor. A feedback repressor pathway regulating
Wnt signaling. J Biol Chem. 277:21657-21665.
-
Leung SY, Chen X, Chu KM, Yuen ST, Mathy J,
Ji J, Chan ASY, Li R, Law S, Troyanskaya OG, Tum I-P, Wong J, So S, Botstein
D, Brown PO. (2002). Phospholipase A2 group IIA expression in gastric adenocarcinoma
is associated with prolonged survival and less frequent metastasis. Proc
Natl Acad Sci USA. 99:16203-16208.
-
Lieberfarb ME, Lin M, Lechpammer M, Li C,
Tanenbaum DM, Febbo PG, Wright RL, Shim J, Kantoff PW, Loda M, Meyerson
M, Sellers WR. (2003). Genome-wide loss of heterozygosity analysis from
laser capture microdissected prostate cancer using single nucleotide polymorphic
allele (SNP) arrays and a novel bioinformatics platform dChipSNP.
Cancer Res. 63:4781-4785.
-
Lin F, Yu YP, Woods J, Cieply K, Gooding B,
Finkelstein P, Dhir R, Krill D, Becich MJ, Michalopoulos G, Finkelstein
S, Luo JH. (2001). Myopodin, a synaptopodin homologue, is frequently deleted
in invasive prostate cancers. Am J Pathol. 159:1603-1612.
-
Lindblad-Toh K, Tanenbaum DM, Daly MJ, Winchester
E, Lui WO, Villapakkam A, Stanton SE, Larsson C, Hudson TJ, Johnson BE,
Lander ES, Meyerson M. (2000). Loss-of-heterozygosity analysis of small-cell
lung carcinomas using single-nucleotide polymorphism arrays. Nat Biotechnol.
18:1001-1005.
-
Linn SC, West RB, Pollack JR, Zhu S, Hernandez-Boussard
T, Nielsen TO, Rubin BP, Patel R, Goldblum JR, Siegmund D, Botstein D,
Brown PO, Gilks CB, van de Rijn M. (2003). Gene expression patterns and
gene copy number changes in dermatofibrosarcoma protuberans. Am J Pathol.
163:2383-2395.
-
Liu CL, Prapong W, Natkunam Y, Alizadeh A,
Montgomery K, Gilks CB, van de Rijn M. (2002). Software Tools for High-Throughput
Analysis and Archiving of Immunohistochemistry Staining Data Obtained with
Tissue Microarrays. Am J Pathol. 161: 1557-1565.
-
Logsdon CD, Simeone DM, Binkley C, Arumugam
T, Greenson JK, Giordano TJ, Misek DE, Kuick R, Hanash S. (2003). Molecular
profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies
multiple genes differentially regulated in pancreatic cancer. Cancer Res.
63:2649-2657.
-
Lonning PE, Sorlie T, Perou CM, Brown PO,
Botstein D, Borresen-Dale AL. (2001). Microarrays in primary breast
cancer--lessons from chemotherapy studies. Endocr Relat Cancer. 8:259-263.
-
Lossos IS, Alizadeh AA, Eisen MB, Chan WC,
Brown PO, Botstein D, Staudt LM, Levy R. (2000). Ongoing immunoglobulin
somatic mutation in germinal center B cell-like but not in activated B
cell-like diffuse large cell lymphomas. Proc Natl Acad Sci USA. 97:10209-10213.
-
Luo JH. (2002). Gene expression alterations
in human prostate cancer. Drugs Today. 38:713-719. Review.
-
Lu KV, Jong KA, Rajasekaran AK, Cloughesy
TF, Mischel PS. (2004) Upregulation of tissue inhibitor of metalloproteinases
(TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell
invasion in a human glioblastoma cell line. Lab Invest. 84:8-20.
-
Luo JH, Yu YP, Cieply K, Lin F, Deflavia P,
Dhir R, Finkelstein S, Michalopoulos G, Becich M. (2002). Gene expression
analysis of prostate cancers. Mol Carcinog. 33:25-35.
-
Madoz-Gurpide J, Hanash SM. (2003). Molecular
analysis of cancer using DNA and protein microarrays. Adv Exp Med Biol.
532:51-58. Review.
-
Malek RL, Irby RB, Guo QM, Lee K, Wong S,
He M, Tsai J, Frank B, Liu ET, Quackenbush J, Jove R, Yeatman TJ, Lee NH.
(2002). Identification of Src transformation fingerprint in human colon
cancer. Oncogene. 21:7256-7265.
-
Mariadason JM, Arango D, Corner GA, Arañes
MJ, Hotchkiss KA, Yang W Augenlicht LH. (2002). A Gene Expression Profile
That Defines Colon Cell Maturation in Vitro. Cancer Res. 62:4791-4804.
-
Mariadason JM, Arango D, Shi Q, Wilson AJ,
Corner GA, Nicholas C, Aranes MJ, Lesser M, Schwartz EL, Augenlicht LH.
(2003). Gene expression profiling-based prediction of response of colon
carcinoma cells to 5-fluorouracil and camptothecin. Cancer Res. 63:8791-8812.
-
Masys DR. (2001). Database designs for microarray
data. Pharmacogenomics J. 1:232-233. Masys DR. (2001). Linking microarray
data to the literature. Nat Genet 28:9-10.
-
Masys DR, Welsh JB, Lynn Fink J, Gribskov,M,
Klacansky I, Corbeil J. (2001). Use of keyword hierarchies to interpret
gene expression patterns. Bioinformatics 17:319-326.
-
Meyerson M, Franklin WA, Kelley MJ. (2004).
Molecular classification and molecular genetics of human lung cancers.
Semin Oncol. 31:4-19. Review.
-
Miller CT, Chen G, Gharib TG, Wang H, Thomas
DG, Misek DE, Giordano TJ, Yee J, Orringer MB, Hanash SM, Beer DG. (2003).
Increased C-CRK proto-oncogene expression is associated with an aggressive
phenotype in lung adenocarcinomas. Oncogene. 22:7950-7957.
-
Mischel PS, Cloughesy TF. (2003) Targeted
molecular therapy of GBM. Brain Pathol. 13:52-61. Review.
-
Mischel PS, Nelson SF, Cloughesy TF. (2003).
Molecular Analysis of Glioblastoma: Pathway Profiling and Its Implications
for Patient Therapy. Cancer Biol Ther. 2:242-247.
-
Mischel PS, Shai R, Shi T, Horvath S, Lu KV,
Choe G, Seligson D, Kremen TJ, Palotie A, Liau LM, Cloughesy TF, Nelson
SF. (2003). Identification of molecular subtypes of glioblastoma by gene
expression profiling. Oncogene. 22:2361-2373.
-
Mischel PS, Umbach JA, Eskandari S, Smith
SG, Gundersen CB, Zampighi GA. (2002). Nerve growth factor signals via
preexisting TrkA receptor oligomers. Biophys J. 83:968-976.
-
Misek DE, Chang CL, Kuick R, Hinderer R, Giordano
TJ, Beer DG, Hanash SM. (2002). Transforming properties of a Q18-->E
mutation of the microtubule regulator Op18. Cancer Cell. 2:217-228.
-
Moinova HR, Chen WD, Shen L, Smiraglia D,
Olechnowicz J, Ravi L, Kasturi L, Myeroff L, Plass C, Parsons R, Minna
J, Willson JK, Green SB, Issa JP, Markowitz SD. (2002). HLTF gene silencing
in human colon cancer. Proc Natl Acad Sci USA. 99:4562-4567.
-
Moos PJ, Raetz EA, Carlson MA, Szabo A, Smith
FE, Willman C, Wei Q, Hunger SP, Carroll WL. (2002). Identification of
gene expression profiles that segregate patients with childhood leukemia.
Clin Cancer Res. 8:3118-3130.
-
Moran CJ, Arenberg DA, Huang CC, Giordano
TJ, Thomas DG, Misek DE, Chen G, Iannettoni MD, Orringer MB, Hanash S,
Beer DG. (2002). RANTES Expression Is a Predictor of Survival in Stage
I Lung Adenocarcinoma. Clin Cancer Res. 8:3803-3812.
-
Mukherjee S, Tamayo P, Rogers S, Rifkin R,
Engle A, Campbell C, Golub TR, Mesirov JP. (2003). Abstract Estimating
dataset size requirements for classifying DNA microarray data. J Comput
Biol.10:119-142.
-
Murray JI, Whitfield ML, Trinklein ND, Myers
RM, Brown PO, Botstein D. (2004). Diverse and specific gene expression
responses to stresses in cultured human cells. Mol Biol Cell. [Epub ahead
of print]
-
Nagy PL, Cleary ML, Brown PO, Lieb JD. (2003).
Genomewide demarcation of RNA polymerase II transcription units revealed
by physical fractionation of chromatin. Proc Natl Acad Sci USA. 100:6364-6369.
-
Naoki K, Chen TH, Richards WG, Sugarbaker
DJ, Meyerson M. (2002). Missense Mutations of the BRAF Gene in Human Lung
Adenocarcinoma. Cancer Res. 62:7001-7003.
-
Nielsen TO, Hsu FD, O'Connell JX, Gilks CB,
Sorensen PH, Linn S, West RB, Liu CL, Botstein D, Brown PO, van de Rijn
M. (2003). Tissue microarray validation of epidermal growth factor receptor
and SALL2 in synovial sarcoma with comparison to tumors of similar histology.
Am J Pathol. 163:1449-1456.
-
Nielsen TO, West RB, Linn SC, Alter O, Knowling
MA, O'Connell JX, Zhu S, Fero M, Sherlock G, Pollack JR, Brown PO, Botstein
D, van de Rijn M. (2002). Molecular characterisation of soft tissue tumours:
a gene expression study. Lancet. 359:1301-1307.
-
Oh JM, Brichory F, Puravs E, Kuick R, Wood
C, Rouillard JM, Tra J, Kardia S, Beer D, Hanash S. (2001). A database
of protein expression in lung cancer. Proteomics. 1:1303-1319.
-
Pan Z, Shen Y, Du C, Zhou G, Rosenwald A,
Staudt LM, Greiner TC, McKeithan TW, Chan WC. (2003). Two newly characterized
germinal center B-cell-associated genes, GCET1 and GCET2, have differential
expression in normal and neoplastic B cells. Am J Pathol. 163:135-144.
-
Perou CM, Brown PO, Botstein D. (2000). Tumor
classification using gene expression patterns from DNA microarrays,
New technologies for life sciences: a Trends guide (pp. 67-76), London:
Elsevier Science.
-
Perou CM, Sorlie T, Eisen MB, van de Rijn
M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, JohnsenH, Akslen LA, Fluge
O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL,
Brown PO, Botstein D. (2000). Molecular portraits of human breast tumours.
Nature. 406, 747-752.
-
Platzer P, Upender MB, Wilson K, Willis J,
Lutterbaugh J, Nosrati A, Willson JK, Mack D, Ried T, Markowitz S. (2002).
Silence of chromosomal amplifications in colon cancer. Cancer Res. 62:1134-1138.
-
Pollack JR, Sorlie T, Perou CM, Rees CA, Jeffrey
SS, Lonning PE, Tibshirani R, Botstein D, Borresen-Dale AL, Brown PO. (2002).
Microarray analysis reveals a major direct role of DNA copy number alteration
in the transcriptional program of human breast tumors. Proc Natl Acad Sci
USA. 99:12963-12968.
-
Pollack JR, Van de Rijn M, Botstein D. (2002).
Challenges in developing a molecular characterization of cancer. Semin
Oncol. 29:280-285. Review.
-
Radich JP. (2002). The promise of gene expression
analysis in hematopoetic malignancies. Biochim Biophys Acta. 1602:88-95.
Review.
-
Ramaswamy S, Golub TR. (2002). DNA microarrays
in clinical oncology. J Clin Oncol. 20:1932-1941. Review.
-
Ramaswamy S, Tamayo P, Rifkin R, Mukherjee
S, Yeang CH, Angelo M, Ladd C, Reich M, Latulippe E, Mesirov JP, Poggio
T, Gerald W, Loda M, Lander ES, Golub TR. (2001). Multiclass cancer diagnosis
using tumor gene expression signatures. Proc Natl Acad Sci USA. 98:15149-15154.
-
Ren B, Yu YP, Jing L, Liu L, Michalopoulos
GK, Luo JH, Rao UN. (2003). Gene expression analysis of human soft tissue
leiomyosarcomas. Hum Pathol. 34:549-558.
-
Rosenwald A, Alizadeh AA, Widhopf G, Simon
R, Davis RE, Yu X, Yang L, Pickeral OK, Rassenti LZ, Powell J, Botstein
D, Byrd JC, Grever MR, Cheson BD, Chiorazzi N, Wilson, WH, Kipps TJ, Brown
PO, Staudt LM. (2001). Relation of gene expression phenotype to immunoglobulin
mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med. 194:1639-1647.
-
Rosenwald A, Staudt LM. (2002). Clinical translation
of gene expression profiling in lymphomas and leukemias. Semin Oncol. 29:258-263.
Review.
-
Rosenwald A, Wright G, Chan WC, Connors JM,
Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Giltnane
JM, Hurt EM, Zhao H, Averett L, Yang L, Wilson WH, Jaffe ES, Simon R, Klausner
RD, Powell J, Duffey PL, Longo DL, Greiner TC, Weisenburger DD, Sanger
WG, Dave BJ, Lynch JC, Vose J, Armitage JO, Montserrat E, Lopez-Guillermo
A, Grogan TM, Miller TP, LeBlanc M, Ott G, Kvaloy S, Delabie J, Holte H,
Krajci P, Stokke T, Staudt LM. (2002). The use of molecular profiling to
predict survival after chemotherapy for diffuse large-B-cell lymphoma.
N Engl J Med. 346:1937-1947.
-
Rosenwald A, Wright G, Leroy K, Yu X, Gaulard
P, Gascoyne RD, Chan WC, Zhao T, Haioun C, Greiner TC, Weisenburger DD,
Lynch JC, Vose J, Armitage JO, Smeland EB, Kvaloy S, Holte H, Delabie J,
Campo E, Montserrat E, Lopez-Guillermo A, Ott G, Muller-Hermelink HK, Connors
JM, Braziel R, Grogan TM, Fisher RI, Miller TP, LeBlanc M, Chiorazzi M,
Zhao H, Yang L, Powell J, Wilson WH, Jaffe ES, Simon R, Klausner RD, Staudt
LM. (2003). Molecular diagnosis of primary mediastinal B cell lymphoma
identifies a clinically favorable subgroup of diffuse large B cell lymphoma
related to hodgkin lymphoma. J Exp Med. 198:851-862.
-
Rosenwald A, Wright G, Wiestner A, Chan WC,
Connors JM, Campo E, Gascoyne RD, Grogan TM, Muller-Hermelink HK, Smeland
EB, Chiorazzi M, Giltnane JM, Hurt EM, Zhao H, Averett L, Henrickson S,
Yang L, Powell J, Wilson WH, Jaffe ES, Simon R, Klausner RD, Montserrat
E, Bosch F, Greiner TC, Weisenburger DD, Sanger WG, Dave BJ, Lynch JC,
Vose J, Armitage JO, Fisher RI, Miller TP, LeBlanc M, Ott G, Kvaloy S,
Holte H, Delabie J, Staudt LM. (2003). The proliferation gene expression
signature is a quantitative integrator of oncogenic events that predicts
survival in mantle cell lymphoma. Cancer Cell. 3:185-197.
-
Saghizadeh M, Brown DJ, Tajbakhsh J, Chen
Z, Kenney MC, Farber DB, Nelson SF. (2003). Evaluation of techniques using
amplified nucleic acid probes for gene expression profiling. Biomol Eng.
20:97-106.
-
Sanchez-Izquierdo D, Buchonnet G, Siebert
R, Gascoyne RD, Climent J, Karran L, Marin M, Blesa D, Horsman D, Rosenwald
A, Staudt LM, Albertson DG, Du MQ, Ye H, Marynen P, Garcia-Conde J, Pinkel
D, Dyer MJ, Martinez-Climent JA. (2003). MALT1 is deregulated by both chromosomal
translocation and amplification in B-cell non-Hodgkin lymphoma. Blood.
101:4539-4546.
-
Sayama K, Diehn M, Matsuda K, Lunderius C,
Tsai M, Tam SY, Botstein D, Brown PO, Galli SJ. (2002). Transcriptional
response of human mast cells stimulated via the Fc(epsilon)RI and identification
of mast cells as a source of IL-11. BMC Immunol. 3:5.
-
Schaner ME, Ross DT, Ciaravino G, Sorlie T,
Troyanskaya O, Diehn M, Wang YC, Duran GE, Sikic TL, Caldeira S, Skomedal
H, Tu IP, Hernandez-Boussard T, Johnson SW, O'Dwyer PJ, Fero MJ, Kristensen
GB, Borresen-Dale AL, Hastie T, Tibshirani R, Van De Rijn M, Teng NN, Longacre
TA, Botstein D, Brown PO, Sikic BI. (2003). Gene Expression Patterns in
Ovarian Carcinomas. Mol Biol Cell. 14:4376-4386.
-
Schofield D, Triche TJ. (2002). cDNA microarray
analysis of global gene expression in sarcomas. Curr Opin Oncol 14:406-411.
Review.
-
Schwartz DR, Kardia SL, Shedden KA, Kuick
R, Michailidis G, Taylor JM, Misek DE, Wu R, Zhai Y, Darrah DM, Reed H,
Ellenson LH, Giordano TJ, Fearon ER, Hanash SM, Cho KR. (2002). Gene expression
in ovarian cancer reflects both morphology and biological behavior, distinguishing
clear cell from other poor-prognosis ovarian carcinomas. Cancer Res. 62:4722-4729.
-
Schwartz DR, Wu R, Kardia SL, Levin AM, Huang
CC, Shedden KA, Kuick R, Misek DE, Hanash SM, Taylor JM, Reed H, Hendrix
N, Zhai Y, Fearon ER, Cho KR. (2003). Novel candidate targets of beta-catenin/T-cell
factor signaling identified by gene expression profiling of ovarian endometrioid
adenocarcinomas. Cancer Res. 63:2913-2922.
-
Sellers WR, Loda M. (2002). The EZH2 polycomb
transcriptional repressor -a marker or mover of metastatic prostate cancer?
Cancer Cell 2:349-350.
-
Shai R, Shi T, Kremen TJ, Horvath S, Liau
LM, Cloughesy TF, Mischel PS, Nelson SF. (2003). Gene expression profiling
identifies molecular subtypes of gliomas. Oncogene. 22:4918-493.
-
Shedden KA, Taylor JM, Giordano TJ, Kuick
R, Misek DE, Rennert G, Schwartz DR, Gruber SB, Logsdon C, Simeone D, Kardia
SL, Greenson JK, Cho KR, Beer DG, Fearon ER, Hanash S. (2003). Accurate
molecular classification of human cancers based on gene expression using
a simple classifier with a pathological tree-based framework. Am J Pathol.
163:1985-95.
-
Signoretti S, Di Marcotullio L, Richardson
A, Ramaswamy S, Isaac B, Rue M, Monti F, Loda M, Pagano M. (2002). Oncogenic
role of the ubiquitin ligase subunit Skp2 in human breast cancer. J Clin
Invest. 110:633-641.
-
Simek K, Kimmel M. (2003). A note on estimation
of dynamics of multiple gene expression based on singular value decomposition.
Math Biosci. 182:183-99.
-
Singh D, Febbo PG, Ross K, Jackson DG, Manola
J, Ladd C, Tamayo P, Renshaw AA, D'Amico AV, Richie JP, Lander ES, Loda
M, Kantoff PW, Golub TR, Sellers WR. (2002). Gene expression correlates
of clinical prostate cancer behavior. Cancer Cell. 1:203-209.
-
Siu IM, Lal A, Blankenship JR, Aldosari N,
Riggins GJ. (2003). c-Myc promoter activation in medulloblastoma. Cancer
Res. 63:4773-4776.
-
Sloan DD, Nicholson B, Urquidi V, Goodison
S. (2004). Detection of differentially expressed genes in an isogenic breast
metastasis model using RNA arbitrarily primed-polymerase chain reaction
coupled with array hybridization (RAP-array). Am J Pathol. 164:315-323.
-
Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler
S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T,
Quist H, Matese JC, Brown PO, Botstein D, Eystein Lonning P, Borresen-Dale
AL. (2001). Gene expression patterns of breast carcinomas distinguish tumor
subclasses with clinical implications. Proc Natl Acad Sci USA. 98:10869-10874.
-
Sorlie T, Tibshirani R, Parker J, Hastie T,
Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, Demeter J,
Perou CM, Lonning PE, Brown PO, Borresen-Dale AL, Botstein D. (2003). Repeated
observation of breast tumor subtypes in independent gene expression data
sets. Proc Natl Acad Sci USA. 100:8418-8423.
-
Staudt LM. (2002). Gene expression profiling
of lymphoid malignancies. Annu Rev Med. 53:303-318. Review.
-
Staudt LM. (2003). Molecular diagnosis of
the hematologic cancers. N Engl J Med. 348:1777-1785.
-
Staudt LM, Wilson WH. (2002). Focus on lymphomas.
Cancer Cell. 2:363-366.
-
Stirewalt DL, Pogosova-Agadjanyan EL, Khalid
N, Hare DR, Ladne PA, Sala-Torra O, Zhao LP, Radich JP. (2004). Single-stranded
linear amplification protocol results in reproducible and reliable microarray
data from nanogram amounts of starting RNA. Genomics. 83:321-331.
-
Stuart RO, Wachsman W, Berry CC, Wang-Rodriguez
J, Wasserman L, Klacansky I, Masys D, Arden K, Goodison S, McClelland M,
Wang Y, Sawyers A, Kalcheva I, Tarin D, Mercola D. (2004). In silico dissection
of cell-type-associated patterns of gene expression in prostate cancer.
Proc Natl Acad Sci USA. 101:615-620.
-
Teng S, Sun J, Irby, R, Hamilton AD, Sebti
S, Yeatman TJ. (2001). v-Src transformation is mediated through farnesylated
proteins. J Surg Res. 99: 343-346.
-
Triche TJ, Schofield D, Buckley J. (2001).
DNA microarrays in pediatric cancer. Cancer J. 7:2-15.
-
Tiwari G, Sakaue H, Pollack JR, Roth RA. (2003).
Gene expression profiling in prostate cancer cells with akt activation
reveals fra-1 as an akt-inducible gene. Mol Cancer Res. 1:475-484.
-
Troyanskaya O, Cantor M, Sherlock G, Brown
P, Hastie T, Tibshirani R, Botstein D, Altman RB. (2001). Missing value
estimation methods for DNA microarrays. Bioinformatics. 17:520-525.
-
Troyanskaya OG, Garber ME, Brown PO, Botstein
D, Altman RB. (2002). Nonparametric methods for identifying differentially
expressed genes in microarray data. Bioinformatics. 18:1454-1461.
-
Van De Rijn M, Perou CM, Tibshirani R, Haas
P, Kallioniemi O, Kononen J, Torhorst J, Sauter G, Zuber M, Kochli OR,
Mross F, Dieterich H, Seitz R, Ross D,Botstein D, Brown P. (2002). Expression
of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor
clinical outcome. Am J Pathol. 61:1991-1996.
-
van den Boom J, Wolter M, Kuick R, Misek DE,
Youkilis AS, Wechsler DS, Sommer C, Reifenberger G, Hanash SM. (2003).
Characterization of gene expression profiles associated with glioma progression
using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase
chain reaction. Am J Pathol. 163:1033-1043.
-
Virolle T, Krones-Herzig A, Baron V, De Gregorio
G, Adamson ED, Mercola D. (2003). Egr1 promotes growth and survival of
prostate cancer cells. Identification of novel Egr1 target genes. J Biol
Chem. 278:11802-11810.
-
Wall DB, Kachman MT, Gong S, Hinderer R, Parus
S, Misek DE, Hanash SM, Lubman DM. (2000). Isoelectric focusing nonporous
RP HPLC: a two-dimensional liquid-phase separation method for mapping of
cellular proteins with identification using MALDI-TOF mass spectrometry.
Anal Chem. 72:1099-1111.
-
Wang H, Katchman MT, Schwartz DR, Cho KR,
Lubman DM. (2002). A protein molecular weight map of ES2 clear cell ovarian
carcinoma cells using a 2-D liquid separations/mass mapping technique.
Electrophoresis. 23:3168-3181.
-
Wang Y, Zhu S, Cloughesy TF, Liau LM, Mischel
PS. (2004). p53 disruption profoundly alters the response of human glioblastoma
cells to DNA topoisomerase I inhibition. Oncogene. 23:1283-90.
-
Warner KA, Crawford EL, Zaher A, Coombs RJ,
Elsamaloty H, Roshong-Denk SL, Sharief I, Amurao GV, Yoon Y, Al-Astal AY,
Assaly RA, Hernandez DA, Graves TG, Knight CR, Harr MW, Sheridan TB, DeMuth
JP, Zahorchak RJ, Hammersley JR, Olson DE, Durham SJ, Willey JC. (2003).
The c-myc x E2F-1/p21 interactive gene expression index augments cytomorphologic
diagnosis of lung cancer in fine-needle aspirate specimens. J Mol Diagn.
5:176-183.
-
Whitfield ML, Sherlock G, Saldanha AJ, Murray
JI, Ball CA, Alexander KE, Matese JC, Perou CM, Hurt MM, Brown PO, Botstein
D. (2002). Identification of genes periodically expressed in the human
cell cycle and their expression in tumors. Mol Biol Cell. 13:1977-2000.
-
Whitney AR, Diehn M, Popper SJ, Alizadeh AA,
Boldrick JC, Relman DA, Brown PO. (2003). Individuality and variation in
gene expression patterns in human blood. Proc Natl Acad Sci USA. 100:1896-1901.
-
Wright G, Tan B, Rosenwald A, Hurt EH, Wiestner
A, Staudt LM. (2003). A gene expression-based method to diagnose clinically
distinct subgroups of diffuse large B cell lymphoma. Proc Natl Acad Sci
USA. 100:9991-9996.
-
Wu R, Lin L, Beer DG, Ellenson LH, Lamb BJ,
Rouillard JM, Kuick R, Hanash S, Schwartz DR, Fearon ER, Cho KR. (2003).
Amplification and overexpression of the L-MYC proto-oncogene in ovarian
carcinomas. Am J Pathol. 162:1603-1610.
-
Yang YM, Bost F, Charbono W, Dean N, McKay
R, Rhim JS, Depatie C, Mercola D. (2003). C-Jun NH(2)-terminal kinase mediates
proliferation and tumor growth of human prostate carcinoma. Clin Cancer
Res. 9:391-401.
-
Yang IV, Chen E, Hasseman JP, Liang W, Frank
BC, Wang S, Sharov V, Saeed AI, White J, Li J, Lee NH, Yeatman TJ, Quackenbush
J. (2002). Within the fold: assessing differential expression measures
and reproducibility in microarray assays. Genome Biol. 3:research0062.
-
Zhao H, Hastie T, Whitfield ML, Børresen-Dale
A-L, Jeffrey SS. (2002). Optimization and evaluation of T7 based RNA linear
amplification protocols for cDNA microarray analysis. BMC Genomics. 3:31-45.
-
Zorn KK, Jazaeri AA, Awtrey CS, Gardner GJ,
Mok SC, Boyd J, Birrer MJ. (2003). Choice of normal ovarian control influences
determination of differentially expressed genes in ovarian cancer expression
profiling studies. Clin Cancer Res. 9:4811-4818.
|